Cargando…

In vitro and in vivo characterization of highly purified Human Mesothelioma derived cells

BACKGROUND: Malignant pleural mesothelioma is a rare disease known to be resistant to conventional therapies. A better understanding of mesothelioma biology may provide the rationale for new therapeutic strategies. In this regard, tumor cell lines development has been an important tool to study the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melotti, Alice, Daga, Antonio, Marubbi, Daniela, Zunino, Annalisa, Mutti, Luciano, Corte, Giorgio
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850899/ https://www.ncbi.nlm.nih.gov/pubmed/20175889 http://dx.doi.org/10.1186/1471-2407-10-54

Ejemplares similares

The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells
por: Pattarozzi, Alessandra, et al.
Publicado: (2017)

Expression and activity of eIF6 trigger Malignant Pleural Mesothelioma growth in vivo
por: Miluzio, Annarita, et al.
Publicado: (2015)

Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo
por: Manente, A G, et al.
Publicado: (2013)

Radiosensitization of orthotopic GIC-driven glioblastoma by doxycycline causes skin damage
por: Frosina, Guido, et al.
Publicado: (2019)

Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
por: Porta, Camillo, et al.
Publicado: (2008)

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
por: Guazzelli, Alice, et al.
Publicado: (2019)

Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo
por: Benvenuto, Monica, et al.
Publicado: (2023)

Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives
por: Gray, Steven G., et al.
Publicado: (2020)

A Glimpse in the Future of Malignant Mesothelioma Treatment
por: Pezzicoli, Gaetano, et al.
Publicado: (2021)

Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells
por: Banelli, Barbara, et al.
Publicado: (2017)

Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021)

ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration
por: Fròsina, Guido, et al.
Publicado: (2018)

Intratumor microbiota as a novel potential prognostic indicator in mesothelioma
por: Pentimalli, Francesca, et al.
Publicado: (2023)

Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
por: Nabavi, Noushin, et al.
Publicado: (2016)

Cdh4 Down-Regulation Impairs in Vivo Infiltration and Malignancy in Patients Derived Glioblastoma Cells
por: Ceresa, Davide, et al.
Publicado: (2019)

Stryphnodendron adstringens and purified tannin on Pythium insidiosum: in vitro and in vivo studies
por: Trolezi, Rodrigo, et al.
Publicado: (2017)

Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
por: Yang, Huanjie, et al.
Publicado: (2012)

p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification
por: Tian, Kun, et al.
Publicado: (2018)

Biological characterization of purified macrophage-derived neutrophil chemotactic factor
por: Dias-Baruffi, M., et al.
Publicado: (1995)

Enrichment of in vitro and in vivo immunologic activity of purified fractions of calf thymic hormone
Publicado: (1978)

PRMT5 silencing selectively affects MTAP‐deleted mesothelioma: In vitro evidence of a novel promising approach
por: Barbarino, Marcella, et al.
Publicado: (2020)

The Interaction of Hemin, a Porphyrin Derivative, with the Purified Rat Brain 2-Oxoglutarate Carrier
por: Miniero, Daniela Valeria, et al.
Publicado: (2021)

Correction: Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
por: Yang, Huanjie, et al.
Publicado: (2013)

In Vitro and In Vivo Anti-tumoral Effects of the Flavonoid Apigenin in Malignant Mesothelioma
por: Masuelli, Laura, et al.
Publicado: (2017)

Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2012)

Spectroscopic Characterization of Bovine, Avian and Johnin Purified Protein Derivative (PPD) with High-Throughput Fourier Transform InfraRed-Based Method
por: Corneli, Sara, et al.
Publicado: (2019)

In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative
por: Ruzza, Chiara, et al.
Publicado: (2015)

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
por: Meirson, Tomer, et al.
Publicado: (2022)

Warifteine, an Alkaloid Purified from Cissampelos sympodialis, Inhibits Neutrophil Migration In Vitro and In Vivo
por: Lima, Thaline F. A., et al.
Publicado: (2014)

Investigation of the In Vivo, In Vitro, and In Silico Wound Healing Potential of Pinctada martensii Purified Peptides
por: Zhang, Ting, et al.
Publicado: (2022)

MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma
por: Melaiu, Ombretta, et al.
Publicado: (2014)

The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo
por: Blum, Walter, et al.
Publicado: (2019)

Effect of the BH3 Mimetic Polyphenol (–)-Gossypol (AT-101) on the in vitro and in vivo Growth of Malignant Mesothelioma
por: Benvenuto, Monica, et al.
Publicado: (2018)

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma
por: Melaiu, Ombretta, et al.
Publicado: (2017)

PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1
por: Pinton, Giulia, et al.
Publicado: (2013)

Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma
por: Volta, Viviana, et al.
Publicado: (2013)

Characterization of smooth muscle differentiation of purified human skeletal muscle-derived cells
por: Lu, Shing-Hwa, et al.
Publicado: (2011)

Composition and Potency Characterization of Mycobacterium avium subsp. paratuberculosis Purified Protein Derivatives
por: Capsel, Randal T., et al.
Publicado: (2016)

IN VITRO AND IN VIVO STUDIES OF THE IMMUNE RESPONSE TO SHEEP ERYTHROCYTES USING PARTIALLY PURIFIED CELL PREPARATIONS
por: Haskill, J. S., et al.
Publicado: (1970)

Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress
por: Garva, Richa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_no1bje70k2mi4s6ifql5mbj6j1